{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T10:16:39Z","timestamp":1781777799802,"version":"3.54.5"},"reference-count":61,"publisher":"Deutscher Arzte-Verlag GmbH","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"DOI":"10.3238\/arztebl.2020.0725","type":"journal-article","created":{"date-parts":[[2020,10,14]],"date-time":"2020-10-14T17:04:11Z","timestamp":1602695051000},"source":"Crossref","is-referenced-by-count":10,"title":["Hormonal Gender Reassignment Treatment for Gender Dysphoria"],"prefix":"10.3238","author":[{"given":"Gesine","family":"Meyer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ute","family":"Boczek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00f6rg","family":"Bojunga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"11437","published-online":{"date-parts":[[2020,10,23]]},"reference":[{"key":"10.3238\/arztebl.2020.0725_ref1","doi-asserted-by":"crossref","unstructured":"Wiepjes CM, Nota NM, de Blok CJM, et al.: The Amsterdam Cohort of Gender Dysphoria Study (1972\u20132015): Trends in prevalence, treatment, and regrets. J Sex Med 2018; 15: 582\u201390","DOI":"10.1016\/j.jsxm.2018.01.016"},{"key":"10.3238\/arztebl.2020.0725_ref2","doi-asserted-by":"crossref","unstructured":"Meyer G, Mayer M, Mondorf A, Herrmann E, Bojunga J: Increasing normality\u2013persisting barriers: current socio-demographic characteristics of 350 individuals diagnosed with gender dysphoria. Clin Endocrinol (Oxf) 2020; 92: 241\u20136","DOI":"10.1111\/cen.14140"},{"key":"10.3238\/arztebl.2020.0725_ref3","doi-asserted-by":"crossref","unstructured":"Bauer GR, Scheim AI, Pyne J, Travers R, Hammond R: Intervenable factors associated with suicide risk in transgender persons: a respondent driven sampling study in Ontario, Canada Health behavior, health promotion and society. BMC Public Health 2015; 15: 525","DOI":"10.1186\/s12889-015-1867-2"},{"key":"10.3238\/arztebl.2020.0725_ref4","doi-asserted-by":"crossref","unstructured":"Wierckx K, Elaut E, Declercq E, et al.: Prevalence of cardiovascular disease and cancer during cross-sex hormone therapy in a large cohort of trans persons: a case-control study. Eur J Endocrinol 2013; 169: 471\u20138","DOI":"10.1530\/EJE-13-0493"},{"key":"10.3238\/arztebl.2020.0725_ref5","doi-asserted-by":"crossref","unstructured":"Murad MH, Elamin MB, Garcia MZ, et al.: Hormonal therapy and sex reassignment: a systematic review and meta-analysis of quality of life and psychosocial outcomes. Clin Endocrinol (Oxf) 2010; 72: 214\u201331","DOI":"10.1111\/j.1365-2265.2009.03625.x"},{"key":"10.3238\/arztebl.2020.0725_ref6","doi-asserted-by":"crossref","unstructured":"Fisher AD, Castellini G, Ristori J, et al.: Cross-sex hormone treatment and psychobiological changes in transsexual persons: two-year follow-up data. J Clin Endocrinol Metab 2016; 101: 4260\u20139","DOI":"10.1210\/jc.2016-1276"},{"key":"10.3238\/arztebl.2020.0725_ref7","doi-asserted-by":"crossref","unstructured":"Jaffee KD, Shires DA, Stroumsa D: Discrimination and delayed health care among transgender women and men implications for improving medical education and health care delivery. Med Care 2016; 54: 1010\u20136","DOI":"10.1097\/MLR.0000000000000583"},{"key":"10.3238\/arztebl.2020.0725_ref8","doi-asserted-by":"crossref","unstructured":"Safer JD, Tangpricha V: Care of transgender persons. N Engl J Med 2019; 381: 2451\u201360","DOI":"10.1056\/NEJMcp1903650"},{"key":"10.3238\/arztebl.2020.0725_ref9","doi-asserted-by":"crossref","unstructured":"Hembree WC, Cohen-Kettenis PT, Gooren L, et al.: Endocrine treatment of gender-dysphoric\/gender-incongruent persons: an endocrine societyclinical practice guideline. J Clin Endocrinol Metab 2017; 102: 3869\u2013903","DOI":"10.1210\/jc.2017-01658"},{"key":"10.3238\/arztebl.2020.0725_ref10","doi-asserted-by":"crossref","unstructured":"Coleman E, Bockting W, Botzer M, et al.: Standards of care for the health of transsexual, transgender, and gender nonconforming people, Version 7. Int J Transgenderism 2012; 13: 165\u2013232","DOI":"10.1080\/15532739.2011.700873"},{"key":"10.3238\/arztebl.2020.0725_ref11","unstructured":"AWMF-Register-Nr. 138|001: Geschlechtsinkongruenz, Geschlechtsdysphorie und Trans-Gesundheit. https:\/\/www.awmf.org\/uploads\/tx_szleitlinien\/138-001l_S3_Geschlechtsdysphorie-Diagnostik-Beratung-Behandlung_2019-02.pdf (last accessed on 9 June 2020)."},{"key":"10.3238\/arztebl.2020.0725_ref12","doi-asserted-by":"crossref","unstructured":"van Kesteren PJM, Asscheman H, Megens JAJ, Gooren LJG: Mortality and morbidity in transsexual subjects treated with cross-sex hormones. Clin Endocrinol (Oxf) 1997; 47: 337\u201342","DOI":"10.1046\/j.1365-2265.1997.2601068.x"},{"key":"10.3238\/arztebl.2020.0725_ref13","doi-asserted-by":"crossref","unstructured":"Asscheman H, Giltay EJ, Megens JAJ, De Ronde W, Van Trotsenburg MAA, Gooren LJG: a long-term follow-up study of mortality in transsexuals receiving treatment with cross-sex hormones. Eur J Endocrinol 2011; 164: 635\u201342","DOI":"10.1530\/EJE-10-1038"},{"key":"10.3238\/arztebl.2020.0725_ref14","doi-asserted-by":"crossref","unstructured":"Toorians AWFT, Thomassen MCLGD, Zweegman S, et al.: Venous thrombosis and changes of hemostatic variables during cross-sex hormone treatment in transsexual people. J Clin Endocrinol Metab 2003; 88: 5723\u20139","DOI":"10.1210\/jc.2003-030520"},{"key":"10.3238\/arztebl.2020.0725_ref15","doi-asserted-by":"crossref","unstructured":"Sweetland S, Beral V, Balkwill A, et al.: Venous thromboembolism risk in relation to use of different types of postmenopausal hormone therapy in a large prospective study. J Thromb Haemost 2012; 10: 2277\u201386","DOI":"10.1111\/j.1538-7836.2012.04919.x"},{"key":"10.3238\/arztebl.2020.0725_ref16","doi-asserted-by":"crossref","unstructured":"Gooren LJ, Giltay EJ, Bunck MC: Long-term treatment of transsexuals with cross-sex hormones: extensive personal experience. J Clin Endocrinol Metab 2008; 93: 19\u201325","DOI":"10.1210\/jc.2007-1809"},{"key":"10.3238\/arztebl.2020.0725_ref17","doi-asserted-by":"crossref","unstructured":"Meyer G, Mayer M, Mondorf A, Fluegel AK, Herrmann E, Bojunga J: Safety and rapid efficacy of guideline-based gender affirming hormone therapy: an analysis of 388 individuals diagnosed with gender dysphoria. Eur J Endocrinol 2020; 182: 149\u201356","DOI":"10.1530\/EJE-19-0463"},{"key":"10.3238\/arztebl.2020.0725_ref18","doi-asserted-by":"crossref","unstructured":"Wierckx K, Gooren L, T\u2019Sjoen G: Clinical review: Breast development in trans women receiving cross-sex hormones. J Sex Med 2014; 11: 1240\u20137","DOI":"10.1111\/jsm.12487"},{"key":"10.3238\/arztebl.2020.0725_ref19","doi-asserted-by":"crossref","unstructured":"Seal LJ: A review of the physical and metabolic effects of cross-sex hormonal therapy in the treatment of gender dysphoria. Ann Clin Biochem 2016; 53: 10\u201320","DOI":"10.1177\/0004563215587763"},{"key":"10.3238\/arztebl.2020.0725_ref20","doi-asserted-by":"crossref","unstructured":"Asscheman H, T\u2019Sjoen G, Lemaire A, et al.: Venous thrombo-embolism as a complication of cross-sex hormone treatment of male-to-female transsexual subjects: a review. Andrologia 2014; 46: 791\u20135","DOI":"10.1111\/and.12150"},{"key":"10.3238\/arztebl.2020.0725_ref21","doi-asserted-by":"crossref","unstructured":"Defreyne J, Van de Bruaene LDL, Rietzschel E, Van Schuylenbergh J, T\u2019Sjoen GGR: Effects of gender-affirming hormones on lipid, metabolic, and cardiac surrogate blood markers in transgender persons. Clin Chem 2019; 65: 119\u201334","DOI":"10.1373\/clinchem.2018.288241"},{"key":"10.3238\/arztebl.2020.0725_ref22","doi-asserted-by":"crossref","unstructured":"Arnold JD, Sarkodie EP, Coleman ME, Goldstein DA: Incidence of venous thromboembolism in transgender women receiving oral estradiol. J Sex Med 2016; 13: 1773\u20137","DOI":"10.1016\/j.jsxm.2016.09.001"},{"key":"10.3238\/arztebl.2020.0725_ref23","doi-asserted-by":"crossref","unstructured":"Boskey ER, Taghinia AH, Ganor O: Association of surgical risk with exogenous hormone use in transgender patients: a systematic review. JAMA Surg 2019; 154: 159\u201369","DOI":"10.1001\/jamasurg.2018.4598"},{"key":"10.3238\/arztebl.2020.0725_ref24","doi-asserted-by":"crossref","unstructured":"Shatzel JJ, Connelly KJ, DeLoughery TG: Thrombotic issues in transgender medicine: a review. Am J Hematol 2017; 92: 204\u20138","DOI":"10.1002\/ajh.24593"},{"key":"10.3238\/arztebl.2020.0725_ref25","doi-asserted-by":"crossref","unstructured":"Pelusi C, Costantino A, Martelli V, et al.: Effects of three different testosterone formulations in female-to-male transsexual persons. J Sex Med 2014; 11: 3002\u201311","DOI":"10.1111\/jsm.12698"},{"key":"10.3238\/arztebl.2020.0725_ref26","doi-asserted-by":"crossref","unstructured":"Elbers JMH, Giltay EJ, Teerlink T, et al.: Effects of sex steroids on components of the insulin resistance syndrome in transsexual subjects. Clin Endocrinol (Oxf) 2003; 58: 562\u201371","DOI":"10.1046\/j.1365-2265.2003.01753.x"},{"key":"10.3238\/arztebl.2020.0725_ref27","doi-asserted-by":"crossref","unstructured":"Wierckx K, Van Caenegem E, Schreiner T, et al.: Cross-sex hormone therapy in trans persons is safe and effective at short-time follow-up: results from the European network for the investigation of gender incongruence. J Sex Med 2014; 11: 1999\u20132011","DOI":"10.1111\/jsm.12571"},{"key":"10.3238\/arztebl.2020.0725_ref28","doi-asserted-by":"crossref","unstructured":"Nota NM, Wiepjes CM, De Blok CJM, Gooren LJG, Kreukels BPC, Den Heijer M: Occurrence of acute cardiovascular events in transgender individuals receiving hormone therapy results from a large cohort study. Circulation 2019; 139: 1461\u20132","DOI":"10.1161\/CIRCULATIONAHA.118.038584"},{"key":"10.3238\/arztebl.2020.0725_ref29","doi-asserted-by":"crossref","unstructured":"Getahun D, Nash R, Flanders WD, et al.: Cross-sex hormones and acute cardiovascular events in transgender persons: a cohort study. Ann Intern Med 2018; 169: 205\u201313 CrossRef","DOI":"10.7326\/M17-2785"},{"key":"10.3238\/arztebl.2020.0725_ref30","doi-asserted-by":"crossref","unstructured":"Tangpricha V, den Heijer M: Oestrogen and anti-androgen therapy for transgender women. Lancet Diabetes Endocrinol 2017; 5: 291\u2013300","DOI":"10.1016\/S2213-8587(16)30319-9"},{"key":"10.3238\/arztebl.2020.0725_ref31","doi-asserted-by":"crossref","unstructured":"Gooren LJ, T\u2019Sjoen G: Endocrine treatment of aging transgender people. Rev Endocr Metab Disord 2018; 19: 253\u201362","DOI":"10.1007\/s11154-018-9449-0"},{"key":"10.3238\/arztebl.2020.0725_ref32","doi-asserted-by":"crossref","unstructured":"Cunha FS, Domenice S, C\u00e2mara VL, et al.: Diagnosis of prolactinoma in two male-to-female transsexual subjects following high-dose cross-sex hormone therapy. Andrologia 2015; 47: 680\u20134","DOI":"10.1111\/and.12317"},{"key":"10.3238\/arztebl.2020.0725_ref33","doi-asserted-by":"crossref","unstructured":"Jindarak S, Nilprapha K, Atikankul T, et al.: Spermatogenesis abnormalities following hormonal therapy in transwomen. Biomed Res Int 2018; 2018: 7919481","DOI":"10.1155\/2018\/7919481"},{"key":"10.3238\/arztebl.2020.0725_ref34","doi-asserted-by":"crossref","unstructured":"Giltay EJ, Gooren LJG: Effects of sex steroid deprivation\/administration on hair growth and skin sebum production in transsexual males and females. J Clin Endocrinol Metab 2000; 85: 2913\u201321","DOI":"10.1210\/jcem.85.8.6710"},{"key":"10.3238\/arztebl.2020.0725_ref35","doi-asserted-by":"crossref","unstructured":"Motosko CC, Zakhem GA, Pomeranz MK, Hazen A: Acne: a side-effect of masculinizing hormonal therapy in transgender patients. Br J Dermatol 2019; 180: 26\u201330","DOI":"10.1111\/bjd.17083"},{"key":"10.3238\/arztebl.2020.0725_ref36","doi-asserted-by":"crossref","unstructured":"Defreyne J, Vantomme B, Van Caenegem E, et al.: Prospective evaluation of hematocrit in gender-affirming hormone treatment: results from european network for the investigation of gender incongruence. Andrology 2018; 6: 446\u201354","DOI":"10.1111\/andr.12485"},{"key":"10.3238\/arztebl.2020.0725_ref37","doi-asserted-by":"crossref","unstructured":"Francis A, Jasani S, Bachmann G: Contraceptive challenges and the transgender individual. Womens Midlife Health 2018; 4: 12","DOI":"10.1186\/s40695-018-0042-1"},{"key":"10.3238\/arztebl.2020.0725_ref38","doi-asserted-by":"crossref","unstructured":"De Blok CJM, Klaver M, Wiepjes CM, et al.: Breast development in transwomen after 1 year of cross-sex hormone therapy: Results of a prospective multicenter study. J Clin Endocrinol Metab 2018; 103: 532\u20138","DOI":"10.1210\/jc.2017-01927"},{"key":"10.3238\/arztebl.2020.0725_ref39","doi-asserted-by":"crossref","unstructured":"De Blok CJM, Wiepjes CM, Nota NM, et al.: Breast cancer risk in transgender people receiving hormone treatment: Nationwide cohort study in the Netherlands. BMJ 2019; 365: 11652","DOI":"10.1136\/bmj.l1652"},{"key":"10.3238\/arztebl.2020.0725_ref40","doi-asserted-by":"crossref","unstructured":"Casella R, Bubendorf L, Schaefer DJ, Bachmann A, Gasser TC, Sulser T: Does the prostate really need androgens to grow? Transurethral resection of the prostate in a male-to-female transsexual 25 years after sex-changing operation. Urol Int 2005; 75: 288\u201390","DOI":"10.1159\/000087811"},{"key":"10.3238\/arztebl.2020.0725_ref41","doi-asserted-by":"crossref","unstructured":"Fisher AD, Bandini E, Casale H, et al.: Sociodemographic and clinical features of gender identity disorder: an Italian multicentric evaluation. J Sex Med 2013; 10: 408\u201319","DOI":"10.1111\/j.1743-6109.2012.03006.x"},{"key":"10.3238\/arztebl.2020.0725_ref42","doi-asserted-by":"crossref","unstructured":"G\u00f3mez-Gil E, Trilla A, Salamero M, God\u00e1s T, Vald\u00e9s M: Sociodemographic, clinical, and psychiatric characteristics of transsexuals from Spain. Arch Sex Behav 2009; 38: 378\u201392","DOI":"10.1007\/s10508-007-9307-8"},{"key":"10.3238\/arztebl.2020.0725_ref43","doi-asserted-by":"crossref","unstructured":"Garrels L, Kockott G, Michael N, et al.: Sex ratio of transsexuals in Germany: the development over three decades. Acta Psychiatr Scand 2000; 102: 445\u20138","DOI":"10.1034\/j.1600-0447.2000.102006445.x"},{"key":"10.3238\/arztebl.2020.0725_ref44","doi-asserted-by":"crossref","unstructured":"Safer JD, Coleman E, Feldman J, et al.: Barriers to healthcare for transgender individuals. Curr Opin Endocrinol Diabetes Obes 2016; 23: 168\u201371","DOI":"10.1097\/MED.0000000000000227"},{"key":"10.3238\/arztebl.2020.0725_ref45","doi-asserted-by":"crossref","unstructured":"Colizzi M, Costa R, Pace V, Todarello O: Hormonal treatment reduces psychobiological distress in gender identity disorder, independently of the attachment style. J Sex Med 2013; 10: 3049\u201358","DOI":"10.1111\/jsm.12155"},{"key":"10.3238\/arztebl.2020.0725_ref46","unstructured":"New Health Guidelines Propel Transgender Rights: Human Rights Watch. www.hrw.org\/news\/2019\/05\/27\/new-health-guidelines-propel-transgender-rights (last accessed on 23 December 2019)."},{"key":"10.3238\/arztebl.2020.0725_ref47","unstructured":"Tessa Ganserer \u2013 Transfrau im Landtag: \u201eIch verlange, dass dieser Staat mich akzeptiert\u201d \u2013 SPIEGEL ONLINE. www.spiegel.de\/politik\/deutschland\/tessa-ganserer-transfrau-im-landtag-ich-verlange-dass-dieser-staat-mich-akzeptiert-a-1302193.html (last accessed on 23 December 2019)."},{"key":"10.3238\/arztebl.2020.0725_ref48","doi-asserted-by":"crossref","unstructured":"The Lancet: Creating respectful health care for trans patients. Lancet 2019; 394 (10192): 2. doi: 10.1016\/S0140\u20136736(19)31522\u20133","DOI":"10.1016\/S0140-6736(19)31522-3"},{"key":"10.3238\/arztebl.2020.0725_ref49","doi-asserted-by":"crossref","unstructured":"Duvivier RJ, Wiley E: WHO\u2019s slow progress on transgender and gender diverse health. Lancet 2019; 394: 1901","DOI":"10.1016\/S0140-6736(19)31890-2"},{"key":"10.3238\/arztebl.2020.0725_ref50","doi-asserted-by":"crossref","unstructured":"Hackl AM, Becker AB, Todd ME: \u201cI Am Chelsea Manning\u201d: Comparison of gendered representation of private manning in U.S. and international news media. J Homosex 2016; 63: 467\u201386","DOI":"10.1080\/00918369.2015.1088316"},{"key":"10.3238\/arztebl.2020.0725_ref51","doi-asserted-by":"crossref","unstructured":"Sineath RC, Woodyatt C, Sanchez T, et al: Determinants of and barriers to hormonal and surgical treatment receipt among transgender people. Transgender Heal 2016; 1: 129\u201336","DOI":"10.1089\/trgh.2016.0013"},{"key":"10.3238\/arztebl.2020.0725_ref52","unstructured":"Medizinischer Dienst des Spitzenverbandes Bund der Krankenkassen e.V. (MDS): Begutachtungsanleitung Geschlechtsangleichende Ma\u00dfnahmen bei Transsexualit\u00e4t. Grundlagen der Begutachtung. 2009. www.mds-ev.de (last accessed on 9 June 2020)."},{"key":"10.3238\/arztebl.2020.0725_ref53","doi-asserted-by":"crossref","unstructured":"Cools M, Nordenstr\u00f6m A, Robeva R, et al.: Caring for individuals with a difference of sex development (DSD): a consensus statement. Nat Rev Endocrinol 2018; 14: 415\u201329","DOI":"10.1038\/s41574-018-0010-8"},{"key":"10.3238\/arztebl.2020.0725_ref54","doi-asserted-by":"crossref","unstructured":"Moore E, Wisniewski A, Dobs A: Endocrine treatment of transsexual people: a review of treatment regimens, outcomes, and adverse effects. J Clin Endocrinol Metab 2003; 88: 3467\u201373","DOI":"10.1210\/jc.2002-021967"},{"key":"10.3238\/arztebl.2020.0725_ref55","doi-asserted-by":"crossref","unstructured":"Manson JAE, Chlebowski RT, Stefanick ML, et al.: Menopausal hormone therapy and health outcomes during the intervention and extended poststopping phases of the women\u2019s health initiative randomized trials. Obstet Gynecol Surv 2014; 69: 83\u20135","DOI":"10.1097\/01.ogx.0000444679.66386.38"},{"key":"10.3238\/arztebl.2020.0725_ref56","doi-asserted-by":"crossref","unstructured":"Mohammed K, Abu Dabrh AM, Benkhadra K, et al.: Oral vs transdermal estrogen therapy and vascular events: a systematic review and Meta-analysis. J Clin Endocrinol Metab 2015; 100: 4012\u201320","DOI":"10.1210\/jc.2015-2237"},{"key":"10.3238\/arztebl.2020.0725_ref57","doi-asserted-by":"crossref","unstructured":"Marjoribanks J, Farquhar C, Roberts H, Lethaby A, Lee J: Long-term hormone therapy for perimenopausal and postmenopausal women. Cochrane Database Syst Rev 2017; 1: CD004143","DOI":"10.1002\/14651858.CD004143.pub5"},{"key":"10.3238\/arztebl.2020.0725_ref58","doi-asserted-by":"crossref","unstructured":"Vinogradova Y, Coupland C, Hippisley-Cox J: Use of hormone replacement therapy and risk of venous thromboembolism: nested case-control studies using the QResearch and CPRD databases. BMJ 2019; 364: k4810","DOI":"10.1136\/bmj.k4810"},{"key":"10.3238\/arztebl.2020.0725_ref59","doi-asserted-by":"crossref","unstructured":"Nast A, Dr\u00e9no B, Bettoli V, et al.: European evidence-based (S3) guideline for the treatment of acne\u2013update 2016\u2013short version. J Eur Acad Dermatol Venereol 2016; 30: 1261\u20138","DOI":"10.1111\/jdv.13776"},{"key":"10.3238\/arztebl.2020.0725_ref60","doi-asserted-by":"crossref","unstructured":"Cheng PJ, Pastuszak AW, Myers JB, Goodwin IA, Hotaling JM: Fertility concerns of the transgender patient. Transl Androl Urol 2019; 8: 209\u201318","DOI":"10.21037\/tau.2019.05.09"},{"key":"10.3238\/arztebl.2020.0725_ref61","doi-asserted-by":"crossref","unstructured":"Miksad RA, Bubley G, Church P, et al.: Prostate cancer in a transgender woman 41 years after initiation of feminization. JAMA 2006; 296: 2316\u20137","DOI":"10.1001\/jama.296.19.2316"}],"container-title":["Deutsches \u00c4rzteblatt international"],"original-title":[],"link":[{"URL":"https:\/\/www.aerzteblatt.de\/10.3238\/arztebl.2020.0725","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,6]],"date-time":"2021-12-06T10:28:47Z","timestamp":1638786527000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.aerzteblatt.de\/10.3238\/arztebl.2020.0725"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,23]]},"references-count":61,"URL":"https:\/\/doi.org\/10.3238\/arztebl.2020.0725","relation":{},"ISSN":["1866-0452"],"issn-type":[{"value":"1866-0452","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,10,23]]}}}